The present invention provides neuroprotective preparations, specifically, Dunaliella alga preparations and uses thereof in the treatment and prophylaxis of neurodegenerative disorders, protein misfolding and cognitive decline.

The present invention provides neuroprotective preparations, specifically, Dunaliella alga preparations and uses thereof in the treatment and prophylaxis of neurodegenerative disorders, protein misfolding and cognitive decline.

The invention relates to a composition for the treatment of male infertility. The invention is characterized by a composition comprising L-carnitine and/or acetyl-L-carnitine or prodrugs thereof for the treatment of infertility in men with a sperm concentration of less than 5 million spermatozoa per milliliter.

The invention relates to a composition for the treatment of male infertility. The invention is characterized by a composition comprising L-carnitine and/or acetyl-L-carnitine or prodrugs thereof for the treatment of infertility in men with a sperm concentration of less than 5 million spermatozoa per milliliter.

The present invention is directed to a composition made of a microalgae powder, and a filler or a filler and magnesium. The composition may further include a wax material, an emulsifier, an antioxidant, or their combinations.

The present invention is directed to a composition made of a microalgae powder, and a filler or a filler and magnesium. The composition may further include a wax material, an emulsifier, an antioxidant, or their combinations.

The present invention is directed to a composition made of a microalgae powder, and a filler or a filler and magnesium. The composition may further include a wax material, an emulsifier, an antioxidant, or their combinations.

The present invention is concerned with a photosynthetic scaffold that delivers oxygen and its uses for tissue engineering and the treatment of ischemia.

The present invention is concerned with a photosynthetic scaffold that delivers oxygen and its uses for tissue engineering and the treatment of ischemia.

Composition containing carotenoid pigments of the xanthophyll family, characterized in that said pigments of the xanthophyll family comprise at least diadinoxanthin, or a C.sub.4 to C.sub.36 fatty acid ester of diadinoxanthin and/or violaxanthin, or a C.sub.4 to C.sub.36 fatty acid ester of violaxanthin, for use in the prevention or treatment of cognitive decline or neurodegenerative diseases.